|
Home
>
Newsletters
>
International Pharmaceutical Regulatory Monitor
> China Launches Drug Blacklist Policy for Companies Violating Safety Laws
International Pharmaceutical Regulatory Monitor
October 2012
| Vol.
40 No.
10
China Launches Drug Blacklist Policy for Companies Violating Safety Laws
Drugmakers that are found to have violated China’s safety laws will now be blacklisted and their names published on the State Food and Drug Administration (SFDA) website.
|
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.